Literature DB >> 9494216

[Malaria prevention: the role of the general practitioner].

L Valerio Sallent1, C Roca i Saumell, M J Llorens Morales, J J Mascort i Roca, L Solsona Díaz, D Ferrer-Vidal Cortella.   

Abstract

OBJECTIVE: To find whether the prophylactic measures against malaria used by travellers to the WHO-defined endemic zones are adequate and what role the General Practitioner plays in their prescription.
DESIGN: Descriptive study.
SETTING: El Prat de Llobregat (Barcelona) airport and four Primary Care practices in Barcelona province. PARTICIPANTS: Susceptible travellers coming from zones with effective transmission of the disease. MEASUREMENTS AND
RESULTS: 142 people satisfied the inclusion criteria, average age 32.8 and 52.1% women. 25.4% had visited type A transmission zones; 23.2%, type B; and 48.6%, type C. Trips which were not formally organised made up 61.3% of the total. 75.4% of travellers received health advice before leaving, but only 3.8% asked their G.P.. Indication of prophylactic measures was correct in 108 people (74.6%); there was under-dosage in 4 (2.8%) and incorrect medication in 32 (22.5%). 85.5% of travellers complied with prescribed amounts. 15.6% had pharmacological side-effects.
CONCLUSIONS: At present, there is a hole in primary prophylaxis for malaria for travellers to the WHO's zone A. General Practitioners can and must prefer advice to the traveller on this question.

Entities:  

Mesh:

Year:  1997        PMID: 9494216

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  2 in total

1.  [Travelling immigrants].

Authors:  L Valerio; L Guerrero; O Martínez; M Sabrià; P Garrido; A Fabregat; M D Reina
Journal:  Aten Primaria       Date:  2003-10-15       Impact factor: 1.137

Review 2.  Mefloquine for preventing malaria during travel to endemic areas.

Authors:  Maya Tickell-Painter; Nicola Maayan; Rachel Saunders; Cheryl Pace; David Sinclair
Journal:  Cochrane Database Syst Rev       Date:  2017-10-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.